How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

ATS 2022: Approach to Lung Nodules in 2022

Shaheen Islam

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

Approaching Sarcoidosis Therapy From a 21st Century Perspective

CHEST 2022 Coverage

D. Culver

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

A Radiologist's Approach to Subsolid Pulmonary Nodules

CHEST 2022 Coverage

A. Guttentag

TBC vs CBD in Rheumatoid Arthritis Patients: What Is The Latest Clin…

Daniel Arkfeld

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

UCLA Health

J. Belperio

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Bronchoscopic Imaging for Interstitial Lung Disease

CHEST 2022 Coverage

G. Zhi Cheng

Sarcoidosis: Diagnosis and Management

University of Colorado Department of Medicine

N. Held

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Top Shoulder Problems You See in the Office

UCSF School of Medicine

B. Feeley

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush

Methotrexate and the Gut Microbiome

RheumNow

R. Blank

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher

Progressive ILD on Rheumatic Diseases - The Rheumatologists' Perspec…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

A. Hoffmann-Vold

Management of Pulmonary Fibrosis in Clinical Practice

National Jewish Health

J. Solomon

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush